why choose us

First received: August 22, 2023

Clinical Trial: Empagliflozin Treatment in Kidney Transplant Recipients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Kidney Transplant

Study Type: INTERVENTIONAL


Official Title: An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)

Brief Summary: Kidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD).While early patient and graft survival are excellent, long-term outcomes continue to be challenging.Patient death with existing kidney graft function occurs in about half of all recipients over time.This is primarily due to the development of cardiovascular disease in a patient population with multiple preexisting cardiac disease risk factors.There has been little progress in improving outcomes in…

Read more